Marked systemic hypotension depresses coronary thrombolysis induced by intracoronary administration of recombinant tissue-type plasminogen activator
- 31 December 1992
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 20 (7) , 1626-1633
- https://doi.org/10.1016/0735-1097(92)90459-z
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Effects of flow on recombinant tissue plasminogen activator-induced pulmonary thrombolysisJournal of Applied Physiology, 1991
- Coronary Thrombolysis with Recombinant Tissue Plasminogen ActivatorChest, 1991
- Effects of Hydralazine and Increased Cardiac Output on Recombinant Tissue Plasminogen Activator-Induced Thrombolysis in Canine Pulmonary Embolism*Chest, 1991
- Recombinant tissue-type plasminogen activator in canine embolic pulmonary hypertension. Effects of bolus versus short-term administration on dynamics of thrombolysis and on pulmonary vascular pressure-flow characteristics.Circulation, 1989
- Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.Circulation, 1987
- Acute myocardial infarction treated with intracoronary streptokinase: A report of the society for cardiac angiographyThe American Journal of Cardiology, 1985
- RANDOMISED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1985
- Work in progress: detection of deep venous thrombosis with 99mTc-sulfur colloid.Radiology, 1983
- Uptake of99Tcmcolloid by intravascular clotThe British Journal of Radiology, 1976